ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, supplying promising advancements across different clinical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, additional trusted alternative for therapeutic use